We are an integrated player in the Vitamin D space having a global reach and presence through our facilities in India and Europe. Having 4 decades of experience and a track record associated with the production of Cholesterol and Vitamin D analogs, Dishman Carbogen Amcis Ltd is uniquely placed on developing and manufacturing complex vitamin D and derivative/analogs.
Deploying our comprehensive tool kit of technologies but more importantly, our world-class scientists, we can bring to bear their experience and knowledge to any Vitamin D challenge.
We recognized the need for Vitamin D production, as research indicated that a large proportion of the planet's population had deficiencies in Vitamin D. Realizing that Vitamin D plays an increasingly understood role in strengthening our immune system, we acquired the Vitamin D and cholesterol business of Solvay in 2007. Since then, Dishman Carbogen Amcis Ltd has developed new technology in development and manufacturing capabilities to address this global need.
With rising demand for the application of this raw material in various sectors, and in the pursuit of developing a worldwide supply chain in the supply of Vitamins and its analogs, we have established a WHO cGMP compliant fully integrated manufacturing unit at our Bavla Campus in India for the development of a wide spectrum of products for the pharmaceutical, nutraceutical and holistic animal nutrition verticals of Vitamin D3.
As a natural expansion of our development and manufacture of Vitamin D3 and analogs, we have expanded along the value chain towards the manufacture of our own list of Vitamin D3 Soft Gels Capsules and Analogues:
Products can be made available with private labels with full regulatory support and dossiers available for selected products.